13 reports

  • ANGINA PECTORIS MARKET IN APAC
  • Introduction
  • Angina
  • Beta-Blocker
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG

Hoffmann-La Roche Ltd ##. ## AstraZeneca PLC ##. ## TSH Biopharm Corporation Limited List of Tables Table ## Global Angina Pectoris Drugs Market Outlook, By Region (2014-2023) ($MN) Table ## Global Angina Pectoris Drugs Market Outlook, By Drug Class (2014-2023) ($MN) Table ## Global

  • Angina
  • Asia
  • Europe
  • World
  • Forecast

It also provides a comprehensive understanding of the emerging Phase III therapies for Angina (Angina Pectoris) which can turn out to be future prospective competitors for the marketed products.

  • Angina
  • Chronic Disease
  • World
  • Demand
  • Product Initiative
  • DISEASE DEFINITION
  • NITRATES
  • Angina
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Angina (Angina Pectoris) - Overview
  • Angina (Angina Pectoris) - Therapeutics Development
  • Angina
  • Hospital
  • United States
  • Product Initiative
  • Juventas Therapeutics, Inc.
  • Angina (Angina Pectoris) - Overview
  • Angina (Angina Pectoris) - Therapeutics Assessment
  • Angina
  • Cardiovascular Disease
  • Chronic Disease
  • United States
  • Product Initiative
  • CHRONIC STABLE ANGINA THERAPEUTICS, G7 COUNTRIES, CLINICAL TRIALS BY PHASE, 2017*
  • CHRONIC STABLE ANGINA THERAPEUTICS, GLOBAL, CLINICAL TRIALS IN PROGRESS BY PHASE, 2017*
  • Angina
  • Cardiology
  • Chronic Disease
  • Clinical Trial
  • Gilead Sciences, Inc.
  • Proportion of Chronic Stable Angina to Cardiovascular Clinical Trials, G7 Countries (%), 2016*
  • Chronic Stable Angina Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Angina
  • Chronic Disease
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • Vasospastic Angina Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Vasospastic Angina Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Angina
  • Chronic Disease
  • World
  • Product Initiative
  • Otsuka Pharmaceutical Co., Ltd.
  • Refractory Angina Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Refractory Angina Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Angina
  • Chronic Disease
  • World
  • Product Initiative
  • Les Laboratoires Servier SAS
  • Stable Angina Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Stable Angina Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Angina
  • Cardiovascular Disease
  • Cardiovascular Drug
  • World
  • Product Initiative
  • Proportion of Unstable Angina to Cardiovascular Clinical Trials, E7 Countries (%), 2016*
  • Proportion of Unstable Angina to Cardiovascular Clinical Trials, G7 Countries (%), 2016*
  • Angina
  • Cardiovascular Disease
  • Cardiovascular Drug
  • World
  • Product Initiative

Angina (Angina Pectoris) Overview ##.

  • Angina
  • Chronic Disease
  • Pathology